These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4096489)

  • 1. Nonenzymatic protein glycosylation. I. Lowered erythrocyte membrane fluidity in juvenile diabetes.
    Watała C; Zawodniak M; Bryszewska M; Nowak S
    Ann Clin Res; 1985; 17(6):327-30. PubMed ID: 4096489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.
    Watala C; Winocour PD
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):513-9. PubMed ID: 1457612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro glycation of red blood cell proteins: high levels of glucose lower lipid fluidity of erythrocyte membranes.
    Watała C
    Exp Pathol; 1988; 33(4):233-8. PubMed ID: 3229458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte membrane fluidity as a marker of diabetic retinopathy in type 1 diabetes mellitus.
    Bianchetti G; Viti L; Scupola A; Di Leo M; Tartaglione L; Flex A; De Spirito M; Pitocco D; Maulucci G
    Eur J Clin Invest; 2021 May; 51(5):e13455. PubMed ID: 33210748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of spectrin and deformability defects in diabetic erythrocytes.
    Schwartz RS; Madsen JW; Rybicki AC; Nagel RL
    Diabetes; 1991 Jun; 40(6):701-8. PubMed ID: 2040386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes.
    Miller JA; Gravallese E; Bunn HF
    J Clin Invest; 1980 Apr; 65(4):896-901. PubMed ID: 7358849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does diabetes mellitus affect diphenylhexatriene penetration into erythrocyte membrane ghosts?
    Watała C; Jóźwiak Z
    Biochem Int; 1988 Mar; 16(3):529-41. PubMed ID: 3382422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of normal and glycated human haemoglobin with erythrocyte membranes from normal and diabetic individuals.
    Bryszewska M
    J Clin Chem Clin Biochem; 1988 Dec; 26(12):809-13. PubMed ID: 3235956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on glycosylated plasma proteins in diabetic patients.
    Rehman J; Rahman MA
    J Pak Med Assoc; 1991 Jan; 41(1):16-8. PubMed ID: 1900545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.
    Waczulíkova I; Sikurová L; Cársky J; Strbová L; Krahulec B
    Gen Physiol Biophys; 2000 Dec; 19(4):381-92. PubMed ID: 11409841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus.
    Watala C; Witas H; Olszowska L; Piasecki W
    Int J Exp Pathol; 1992 Oct; 73(5):655-63. PubMed ID: 1329916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of membrane fluidity alterations and lipid disorders in type I diabetic children and adolescents.
    Watała C; Kordacka M; Loba A; Jóźwiak Z; Nowak S
    Acta Diabetol Lat; 1987; 24(2):141-8. PubMed ID: 3630535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes.
    Bryszewska M; Watała C; Torzecka W
    Br J Haematol; 1986 Jan; 62(1):111-6. PubMed ID: 3942692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lowered membrane fluidity of younger erythrocytes in diabetes.
    Kamada T; McMillan DE; Yamashita T; Otsuji S
    Diabetes Res Clin Pract; 1992 Apr; 16(1):1-6. PubMed ID: 1576926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the glycation of erythrocyte membrane proteins and membrane fluidity.
    Bryszewska M; Szosland K
    Clin Biochem; 1988 Jan; 21(1):49-51. PubMed ID: 3345599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced nonenzymatic glycosylation of blood proteins in stored blood.
    Szelényi JG; Földi J; Hollán SR
    Transfusion; 1983; 23(1):11-4. PubMed ID: 6829053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal regulation of cell membrane fluidity in diabetic nephropathy.
    Jones SC; Thomas TH; Marshall SM
    Diabetologia; 1998 Mar; 41(3):337-42. PubMed ID: 9541175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonenzymatic glycosylation of proteins. II. Does glycosylation of low density lipoproteins affect lipid composition of erythrocyte membranes?
    Watała C; Kordacka M
    Ann Clin Res; 1987; 19(3):194-7. PubMed ID: 3674735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.
    Maulucci G; Cordelli E; Rizzi A; De Leva F; Papi M; Ciasca G; Samengo D; Pani G; Pitocco D; Soda P; Ghirlanda G; Iannello G; De Spirito M
    PLoS One; 2017; 12(9):e0184109. PubMed ID: 28880900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in Na+/K(+)-ATPase activity and fluidity of erythrocyte membranes from relatives of insulin dependent diabetic patients.
    Rabini RA; Galassi R; Staffolani R; Vasta M; Fumelli P; Mazzanti L
    Diabetes Res; 1993; 22(1):33-40. PubMed ID: 8200183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.